MSB 4.89% $1.07 mesoblast limited

Ann: Appendix 3Y for Jane Bell, page-9

  1. 2,751 Posts.
    lightbulb Created with Sketch. 1849
    Why didn't Jane Bell buy in at 30c and wait until 85.5?

    Perhaps she was waiting to ensure all her t's were crossed and i's dotted.

    Like the four i's and two t's in " additional consideration"

    Melbourne, Australia; March 26 and New York, USA; March 25, 2024: Mesoblast Limited
    (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases,
    today announced that U.S. FDA has informed the company that following additional considerationthe
    available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of
    the proposed Biologics License Application (BLA) for remestemcel-L for treatment of pediatric patients
    with steroid-refractory acute graft versus host disease (SR-aGVHD).
    “We thank the agency for their collaborative approach. The responses and guidance from FDA are clear
    and provide us with a high level of confidence to refile our BLA for remestemcel-L in children with SRaGVHD,” said Mesoblast CEO Dr. Silviu Itescu


    There are no guarantees in life apart from death


    and major shareholders, their family members and company executives loading up





    Reg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.